Lilandor (Lavender Oil)

Lavender oil’s primary constituents, linalool and linalyl acetate, are thought to interact with the central nervous system. They may modulate GABA‑A receptor activity and influence serotonin pathways, producing calming and sedative effects. Topically, the oil can exert anti‑inflammatory and antimicrobial actions that help alleviate mild skin irritation.

The appropriate dose of Lilandor is determined by the prescribing clinician or the product label. Because the formulation and strength are not standardized, patients should follow the dosage instructions provided on the packaging or given by a qualified healthcare professional. No universal dosing regimen is prescribed.

Safety data for lavender oil in pregnancy and lactation are limited. Pregnant or nursing individuals should consult their healthcare provider before using Lilandor. If approved, it should be used at the lowest effective dose and only for short periods, with close monitoring for any adverse reactions.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity of Lilandor. GNH India works with hospitals, pharmacies and procurement teams worldwide, and will request verification of trade or institutional credentials. The team then provides pricing, availability, shipping details and any necessary import documentation.

Compared with other herbal calming agents such as valerian root or chamomile, lavender oil is distinguished by its aromatic profile and the presence of linalool, which may provide a more rapid calming effect when inhaled or taken orally. Efficacy varies among individuals, and safety profiles differ; lavender oil is generally well‑tolerated but may cause allergic reactions in sensitive users.

Lilandor should be stored at ambient temperature, preferably below 25 °C, in its original container to protect it from moisture, heat and direct sunlight. Keep the product out of reach of children and avoid exposing it to extreme temperatures, which could degrade the oil’s active constituents and affect potency.

Lilandor is intended for oral use. The product is typically supplied as capsules, tablets or liquid drops, and should be taken with water according to the label directions or a healthcare professional’s recommendation. Do not exceed the suggested amount, and avoid crushing or chewing tablets unless the product specifically permits it.

Although generally safe, the most serious risks include allergic reactions that can manifest as skin rash, swelling, or anaphylaxis, and potential interactions that may increase sedation when combined with central nervous system depressants. Users should discontinue use and seek immediate medical attention if they experience difficulty breathing, severe rash, or swelling of the face or throat.

Individuals with known hypersensitivity to lavender oil or any of its components should avoid Lilandor. It is also contraindicated for patients taking strong CNS depressants, anticoagulants, or those with severe liver disease without medical supervision. Children, pregnant or breastfeeding women should only use the product after consulting a qualified healthcare professional.